122 related articles for article (PubMed ID: 10763152)
21. Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: detection and prognostic value.
Weckermann D; Müller P; Wawroschek F; Harzmann R; Riethmüller G; Schlimok G
J Urol; 2001 Aug; 166(2):699-703. PubMed ID: 11458120
[TBL] [Abstract][Full Text] [Related]
22. Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Mavroudis D; Kouroussis C; Mavroudi C; Perraki M; Sivridis E; Georgoulias V
Int J Cancer; 2004 Feb; 108(4):620-7. PubMed ID: 14696130
[TBL] [Abstract][Full Text] [Related]
23. Circulating levels and clinical implications of epithelial membrane antigen and cytokeratin-1 in women with breast cancer: can their ratio improve the results?
Attallah AM; El-Far M; Omran MM; Abdallah SO; El-Desouky MA; El-Dosoky I; Abdelrazek MA; Attallah AA; Elweresh MA; Abdel Hameed GE; Shawki HA; Salama KS; El-Waseef AM
Tumour Biol; 2014 Nov; 35(11):10737-45. PubMed ID: 25073515
[TBL] [Abstract][Full Text] [Related]
24. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
Shariat SF; Roudier MP; Wilcox GE; Kattan MW; Scardino PT; Vessella RL; Erdamar S; Nguyen C; Wheeler TM; Slawin KM
Cancer Res; 2003 Aug; 63(15):4662-70. PubMed ID: 12907647
[TBL] [Abstract][Full Text] [Related]
25. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
[TBL] [Abstract][Full Text] [Related]
26. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS.
Martin VM; Siewert C; Scharl A; Harms T; Heinze R; Ohl S; Radbruch A; Miltenyi S; Schmitz J
Exp Hematol; 1998 Mar; 26(3):252-64. PubMed ID: 9502622
[TBL] [Abstract][Full Text] [Related]
27. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
[TBL] [Abstract][Full Text] [Related]
28. Detection of circulating epithelial cells after surgery for benign breast disease.
Crisan D; Ruark DS; Decker DA; Drevon AM; Dicarlo RG
Mol Diagn; 2000 Mar; 5(1):33-8. PubMed ID: 10837087
[TBL] [Abstract][Full Text] [Related]
29. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
Liu Z; Fusi A; Klopocki E; Schmittel A; Tinhofer I; Nonnenmacher A; Keilholz U
J Transl Med; 2011 May; 9():70. PubMed ID: 21595914
[TBL] [Abstract][Full Text] [Related]
30. Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis.
Thorban S; Rosenberg R; Busch R; Roder RJ
Br J Cancer; 2000 Jul; 83(1):35-9. PubMed ID: 10883665
[TBL] [Abstract][Full Text] [Related]
31. Challenges in the enumeration and phenotyping of CTC.
Coumans FA; Ligthart ST; Uhr JW; Terstappen LW
Clin Cancer Res; 2012 Oct; 18(20):5711-8. PubMed ID: 23014524
[TBL] [Abstract][Full Text] [Related]
32. Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors.
Novaes M; Bendit I; Garicochea B; del Giglio A
Mol Pathol; 1997 Aug; 50(4):209-11. PubMed ID: 9350305
[TBL] [Abstract][Full Text] [Related]
33. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction.
Mapara MY; Körner IJ; Hildebrandt M; Bargou R; Krahl D; Reichardt P; Dörken B
Blood; 1997 Jan; 89(1):337-44. PubMed ID: 8978310
[TBL] [Abstract][Full Text] [Related]
34. Carcinoembryonic antigen mRNA analysis detects micrometastatic cells in blood from lung cancer patients.
Castaldo G; Tomaiuolo R; Sanduzzi A; Ponticiello A; Marchetiello I; Salvatore F
Eur Respir J; 2003 Sep; 22(3):418-21. PubMed ID: 14516129
[TBL] [Abstract][Full Text] [Related]
35. Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes.
Stathopoulos EN; Sanidas E; Kafousi M; Mavroudis D; Askoxylakis J; Bozionelou V; Perraki M; Tsiftsis D; Georgoulias V
Ann Oncol; 2005 Feb; 16(2):240-6. PubMed ID: 15668277
[TBL] [Abstract][Full Text] [Related]
36. Detection of circulating prostatic cells during radical prostatectomy.
Planz B; Szyska P; Valdor M; Boeckmann W; Füzesi L; Jakse G
Urol Res; 1997; 25(6):385-9. PubMed ID: 9443646
[TBL] [Abstract][Full Text] [Related]
37. Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks.
Hong Y; Zhang Q
Tumour Biol; 2016 May; 37(5):5663-74. PubMed ID: 26758432
[TBL] [Abstract][Full Text] [Related]
38. Detection of disseminated tumor cells in peripheral blood of patients with breast cancer: correlation to nodal status and occurrence of metastases.
Taubert H; Blümke K; Bilkenroth U; Meye A; Kutz A; Bartel F; Lautenschläger C; Ulbrich EJ; Nass N; Holzhausen HJ; Koelbl H; Lebrecht A
Gynecol Oncol; 2004 Jan; 92(1):256-61. PubMed ID: 14751168
[TBL] [Abstract][Full Text] [Related]
39. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
Cai QQ; Huang HQ; Lin TX; Jiang WQ
Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
[TBL] [Abstract][Full Text] [Related]
40. Immunomagnetic enrichment and detection of micrometastases in colorectal cancer: correlation with established clinical parameters.
Weihrauch MR; Skibowski E; Koslowsky TC; Voiss W; Re D; Kuhn-Regnier F; Bannwarth C; Siedek M; Diehl V; Bohlen H
J Clin Oncol; 2002 Nov; 20(21):4338-43. PubMed ID: 12409333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
